Compare ANIX & PROP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ANIX | PROP |
|---|---|---|
| Founded | 1982 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 88.8M | 105.6M |
| IPO Year | 2013 | 2008 |
| Metric | ANIX | PROP |
|---|---|---|
| Price | $2.72 | $0.93 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $8.67 | $6.75 |
| AVG Volume (30 Days) | 94.4K | ★ 3.2M |
| Earning Date | 05-27-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 12.82 | ★ 49.06 |
| EPS | ★ N/A | N/A |
| Revenue | $210,000.00 | ★ $7,939,000.00 |
| Revenue This Year | N/A | $81.83 |
| Revenue Next Year | N/A | $18.00 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 413.59 |
| 52 Week Low | $2.44 | $0.77 |
| 52 Week High | $5.46 | $4.33 |
| Indicator | ANIX | PROP |
|---|---|---|
| Relative Strength Index (RSI) | 42.94 | 42.56 |
| Support Level | $2.65 | $0.77 |
| Resistance Level | $3.12 | $1.93 |
| Average True Range (ATR) | 0.12 | 0.09 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 28.21 | 58.15 |
Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.
Prairie Operating Co is a Houston-based independent energy company engaged in the development and acquisition of oil and natural gas resources in the United States. The Company's assets and operations are concentrated in the oil and liquids-rich regions of the Denver-Julesburg (DJ) Basin, with a focus on the Niobrara and Codell formations. The Company is committed to the responsible development of its oil and natural gas resources and is focused on maximizing returns through consistent growth, capital discipline, and sustainable cash flow generation.